Vascular Malformations Market to Grow Substantially by 2034, Assesses DelveInsight | Key Companies – ARTham Therapeutics, Neurelis, Protara Therapeutics, Recursion, Genentech, Vascular Therapies, Palvella Therapeutics

Vascular malformations represent one of the largest and most underserved segments. The current Atreatment options are limited. The market size of vascular malformations is expected to increase during the forecast period (2024–2034) with the increasing prevalence, disease awareness, and…